MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in Indian children

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 141, Issue 6, 2006, Pages 637-642

  Das, Manali ^a   Das Bhowmik, Aneek ^a   Sinha, Swagata ^a   Chattopadhyay, Anindita ^a   Chaudhuri, Keya ^b   Singh, Manoranjan ^a   Mukhopadhyay, Kanchan ^a  

^a Manovikas Biomedical Research and Diagnostic Centre   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

ADHD; MAOA promoter; Repeat polymorphism

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); MITOCHONDRIAL ENZYME;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DISEASE TRANSMISSION; DOPAMINERGIC SYSTEM; FEMALE; GENDER; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MAOA GENE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SCHOOL CHILD; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASE SEQUENCE; CHILD; DNA PRIMERS; FEMALE; HUMANS; INDIA; MALE; MOLECULAR SEQUENCE DATA; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 33748942288     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30385     Document Type: Article

References (45)

1. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revised (DSM-IV-TR). Committee on Nomenclature and Statistics, Washington, D.C.
2. Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC. 1998. cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 85:4934-4938.
3. Biederman J, Spencer T. 1999. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242.
4. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. 1993. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578-580.
5. Cases O, Seif I, Grimsby J, Caspar P, Chen K, Pournin S, Müller U, Auget M, Babinet C, Shih JC, De Maeyer E. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268:1763-1766.
6. Conners CK, Parker JDA, Sitarenios G, Epstein JN. 1998. The Revised Conners' Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol 26:257-268.
7. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon NJ, Kieffer JE, Leventhal BL. 1995. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993-998.
8. Corpet F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 16:10881-10890.
9. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Bella D, Nöthen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624.
10. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, Freitag C, Becker T, Conroy J, Fitzgerald M, Gill M, Hawi Z. 2005. Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: Preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet 134B:110-114.
11. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115-221.
12. Faraone SV, Doyle AE, Mick E, Biederman J. 2001. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052-1057.
13. Furlong RA, Luk H, Walsh C, Rubinsztein DC. 1999. Analysis of monoamine oxidase A (MAOA) gene in bipolar effective disorder by association studies, meta-analysis, and sequencing of the promoter. Am J Med Genet 88:398-406.
14. Gomez R, Harvey J, Quick C, Scharer I, Harris J. 1999. DSM-IV AD/HD: confirmatory factor models, prevalence and gender and age differences based on parents and teacher ratings of Australian primary school children. J Child Psychol Psychiatry 40:265-274.
15. Grimsby J, Lan NC, Neve R, Chen K, Shih JC. 1990. Tissue distribution of human monoamine oxidase A and B mRNA. J Neurochem 55:1166-1169.
16. Grimsby J, Chen K, Wang LJ, Lan NC, Shih JC. 1991. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA 88:3637-3641.
17. Hinds HL, Hendriks RW, Criag IW, Chen ZY. 1992. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif. Genomics 13:896-897.
18. Ito H, Hamajima N, Matsuo K, Okuma K, Sato S, Ueda R, Tajima K. 2003. Monoamine oxidase polymorphisms and smoking behavior in Japanese. Pharmacogenetics 13:73-79.
19. Johnston JP. 1968. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285-1297.
20. Jönsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC. 2000. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 34:239-244.
21. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B, Tan X, Easteal S. 2000. Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. Psychiatr Genet 10:87-90.
22. Knoll J, Magyar K. 1972. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393-408.
23. Kochersperger LM, Parker EL, Siciliano M, Darlington GJ, Denney RM. 1986. Assignment of genes for human monoamine oxidase A and B to the X chromosome. J Neurosci Res 16:601-616.
24. Lawson DC, Turic D, Langley K, Pay HM, Govan CF, Norton N, Hamsphere ML, Owen MJ, O'Donovan MC, Thapar A. 2003. Association analysis of monoamine A and attention deficit hyperactivity disorder. Am J Med Genet 116B:84-89.
25. Levy ER, Powell JF, Buckle VJ, Hsu TP, Breakfield OX, Craig IW. 1989. Localization of human monoamine oxidase to Xp11.23-11.4 by in situ hybridization: Implications for Norrie disease. Genomics 5:368-370.
26. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP. 2002. Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): Preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 7:626-632.
27. Manuck SB, Flory JD, Ferrel RE, Mann JJ, Muldoon MF. 2000. A regulatory polymorphism of monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatr Res 95:9-23.
28. Miller SA, Dykes DD, Polesky HF. 1998. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
29. Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM. 1993. Reversible monoamine oxidase-A inhibitors in resistant major depression. Clin Neuropharmacol 16:S69-S76.
30. Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Francks C, Cantor RM, Mc Cracken JT, McGough JJ, Nelson SF, Monaco AP, Smalley SL. 2003. A genomewide scan for attention deficit/hyperactivity disorder in an extended sample: Suggestive linkage in 17p11. Am J Hum Genet 72:1268-1279.
31. Sabol SZ, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279.
32. Schmidt LG, Sander T, Kuhn S, Smolka M, Rommelspacher H, Samochowiec J, Lesch KP. 2000. Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics. J Neural Transm 107:681-689.
33. Seeger G, Schloss P, Schmidt MH. 2001. Functional polymorphism within the promoter of the serotonin transporter gene is associated with severe hyperkinetic disorders. Mol Psychiatry 6:235-238.
34. Shih JC, Chen K, Ridd MJ. 1999. Monoamine oxidase: From genes to behavior. Annu Rev Neurosci 22:197-217.
35. Smalley SL. 1997. Genetic influences in childhood-onset psychiatric disorders: Autism and attention-deficit/hyperactivity disorder. Am J Hum Genet 60:1276-1282.
36. Solanto MV. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav Brain Res 94:127-152.
37. Spencer T, Biederman J, Wilens T. 1999. Attention deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am 46:915-927.
38. Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Mammalian Gene Collection Program Team. 2002. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci 99:16899-16903.
39. Syagailo YV, Ströber G, Gräble M, Reimer E, Knapp M, Jungkunz G, Okladnova O, Meyer J, Lesch KP. 2001. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders. Am J Med Genet 105:168-171.
40. Wechsler D. 1991. Wechsler intelligence scale for children-third edition: Manual. San Antonio, TX: The Psychological Corporation.
41. Weyler W, Hsu YP, Breakefield XO. 1990. Biochemistry and genetics of monoamine oxidase. Pharmocol Ther 47:391-417.
42. Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein RP. 2002. Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: Possible association with IQ. Am J Med Genet 114:284-287.
43. Yu YW-Y, Tsai S-J, Hong C-J, Chen M-C, Yang C-W. 2005. Association study of a monoamine oxidase A gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 30:1719-1723.
44. Zametkin A, Liotta W. 1998. The neurobiology of attention-deficit/ hyperactivity disorder. J Clin Psychiatry 59:17-23.
45. Zhu Q-S, Grimsby J, Chen K, Shih JC. 1992. Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. J Neurosci 12:4437-4446.